CORDIS · STOP
Surface Transfer of Pathogens
- Код
STOP- Програма
- HORIZON
- Процедура
HORIZON-CL4-2021-RESILIENCE-01-20- Статус
- SIGNED
- Период
- 01.09.2022 – 30.11.2026
Официални данни · CORDIS · синхронизирано 17.10.2026 10:16 · официален запис
Участници
| Организации | Роля | Държава | Безвъзмездна помощ |
|---|---|---|---|
| BUNDESANSTALT FUER MATERIALFORSCHUNG UND -PRUEFUNG | координатор | DE | 1 062 384 € |
| IDRYMA TECHNOLOGIAS KAI EREVNAS | участник | EL | 552 246 € |
| TARTU ULIKOOL | участник | EE | 399 950 € |
| AFFIX LABS OY | участник | FI | 337 250 € |
| APEL LASER SRL | участник | RO | 332 500 € |
| RUDER BOSKOVIC INSTITUTE | участник | HR | 285 030 € |
| ИНСТИТУТ ПО ЕЛЕКТРОНИКА - БАН | участник | BG | 285 000 € |
| SATAKUNNAN AMMATTIKORKEAKOULU OY | участник | FI | 284 905 € |
| UNIVERSITA DEGLI STUDI DI TRIESTE | участник | IT | 283 920 € |
| FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV | участник | DE | 234 518 € |
| ASTIKI MI KERDOSKOPIKI ETAIREIA PROLIPTIKIS PERIVALLONTIKIS KAI ERGASIAKIS IATRIKIS | участник | EL | 207 250 € |
| AMANUENSIS GMBH | асоцииран партньор | CH | |
| EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT | асоцииран партньор | CH | |
| THE UNIVERSITY OF BIRMINGHAM | асоцииран партньор | UK | |
| KING'S COLLEGE LONDON | асоцииран партньор | UK |
Описание
The STOP project will develop antimicrobial and antiviral nanocoatings that can be flexibly or permanently applied to high-touch surfaces. These nanocoatings will be derived from a combination of inorganic nanoparticles, antimicrobial peptides and nanoscale laser surface patterning. The nanocoatings will be thoroughly characterised for their efficacy, using both existing international standards and improved testing methods developed within the project (the new testing methods will be proposed to standards agencies for adoption). Several different active substances will be explored (i) to allow formulation in highly flexible, sprayable, and long-lasting coatings, (ii) provide broad spectrum antimicrobial antiviral activity, and iii) reduce the chances of the development of resistance. To this end, the mode-of-action, and the risk of selection for antimicrobial resistance in bacteria and viruses will be assessed.The flexible nanocoatings will provide a long-lasting (30 days) reduction in bioburden that resembles standards set for microbial colonization of surfaces in hospitals, which can only be reached after intense surface disinfection or permanent introduction of known antimicrobial material such as copper. This effect will be studied in a real-life intervention trail and with epidemiological models. The developed nanocoatings are expected to lead to significant reductions in infectious diseases transmitted from high-touch surfaces, healthcare cost savings, reduction in environmental pollution by disinfectants, and increased preparedness of the EU public health system to future pandemics. The safety of the nanomaterials will be backed up by human and environmental toxicity studies and life cycle analyses. From the beginning, attention will be paid to end-user acceptance, manufacturing scalability, and short-term exploitation by SMEs
Официални данни · CORDIS · синхронизирано 17.10.2026 10:16 · официален запис · Лиценз: © European Union, CC BY 4.0 (Commission reuse policy).